MedTrace Logo

An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors

NCT04539574 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-01-08

Study results available
· View outcomes & findings →

Summary

This trial investigates how well 7T MRI scan works in imaging central nervous system tumors. Diagnostic procedures, such as 7T MRI, may help find and diagnose central nervous system tumors and help measure a patient's response to earlier treatment. The goal of this trial is to learn if a new MRI system can provide better quality images than a standard MRI.

Conditions

  • Central Nervous System Neoplasm
  • Glioma
  • Metastatic Malignant Neoplasm in the Central Nervous System
  • Metastatic Malignant Solid Neoplasm

Interventions

PROCEDURE

7 Tesla Magnetic Resonance Imaging

Undergo 7T MRI

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Max Wintermark · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-04
Primary Completion
2024-04-26
Completion
2024-04-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04539574 on ClinicalTrials.gov